Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve The meeting of Board of Directors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd has informed BSE that its Board of Directors will meet on Tuesday, 29th July 2025 to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter ended 30th June 2025 (Q1 FY26), in line with SEBI Listing Regulations. The trading window for designated persons has already been closed from 1st July 2025 and will remain closed until 48 hours after the results are declared. The meeting may also consider any other matter with the permission of the Chair. No financial numbers have been disclosed in this intimation — they will be shared after the board meeting on 29th July.
This is a routine regulatory filing ahead of the Q1 FY26 results announcement. Shareholders should watch for the actual results on or after 29th July 2025, as the numbers (revenue, profit, margins) will determine near-term stock direction.